Compliance with tricyclic antidepressants: the value of four different methods of assessment.
OBJECTIVE
To assess the advantages and disadvantages of four methods for studying compliance with antidepressants: self-report scores, tablet counts, a microprocessor (MEMS) container system and the assay of nordothiepin and dothiepin concentrations in plasma.


METHODS
The techniques were used in 88 patients commencing tricyclic antidepressants in the setting of UK general practice.


RESULTS
The MEMS system proved to be the most informative technique allowing identification of the precise time of container opening, the demonstration of 'drug holidays' and early cessation of therapy. Self-report scores (Morisky) proved a useful screening technique with a sensitivity of 72.2% and specificity of 74.1% for > or = 80% compliance. Although tablet counts were possible in 84 patients (95. 5%) they were unreliable in 19 (21.6%). Blood concentration assays proved the least acceptable method to patients and were possible in only 53 (60.2%). A ratio of nordothiepin:dothiepin > or = 1.1 claimed, by others, to identify noncompliance was only reliable when concentrations were low.


CONCLUSIONS
Both the MEMS system and self-report scores proved useful methods for identifying noncompliant patients in the setting of UK general practice. Although compliance was higher than reported in previous studies with 70 patients (79.5%) completing 6 weeks treatment, general practitioners tended to prescribe subtherapeutic doses.
Clinical Pharmacology Group, School of Medicine, University of Southampton, Southampton.
C F
CF
George
R C
RC
Peveler
S
S
Heiliger
C
C
Thompson
D000328:Adult; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000097:blood / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy*; D005194:Family Practice; D005260:Female; D006801:Humans; D008297:Male; D008838:Microcomputers; D008875:Middle Aged; D010349:Patient Compliance / Q000523:psychology*; D012646:Self Administration / Q000523:psychology; D006113:United Kingdom / Q000453:epidemiology
D000929:Antidepressive Agents, Tricyclic